Views & Analysis

R&D
12 Questions with Peter Wickersham
Sponsored

12 Questions with Peter Wickersham

Peter Wickersham is the Vice President and General Manager of Gilead Sciences UK & Ireland, and a leader in HIV treatment, liver disease, and oncology.

R&D
Woman looking at buildings

2025 Life sciences real estate predictions

As we commence 2025, for those who are considered leaders or visionaries in their fields, it’s time to dust off the crystal ball and make some bold predictions about what this year will bri

R&D
AI learning and revolution illustration

The AI revolution in pharma

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery.